General Information of the Compound
Compound ID
CP0059457
Compound Name
8-Cyclopentyl-6-ethyl-3-thiophen-2-yl-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacene
    Show/Hide
Synonyms
9-Cyclopentyl-7-ethyl-3-(2-thienyl)-5,6-dihydro-9H-pyrazolo[3,4-c][1,2,4]triazolo[4,3-a]pyridine
CP-325366
TOFIMILAST
Tofimilast < Prop INN
    Show/Hide
Structure
Formula
C18H21N5S
Molecular Weight
339.468
Canonical SMILES
CCc1nn(C2CCCC2)c-2c1CCn1c(nnc-21)-c1cccs1
    Show/Hide
InChI
InChI=1S/C18H21N5S/c1-2-14-13-9-10-22-17(15-8-5-11-24-15)19-20-18(22)16(13)23(21-14)12-6-3-4-7-12/h5,8,11-12H,2-4,6-7,9-10H2,1H3
    Show/Hide
InChIKey
DHCOPPHTVOXDKU-UHFFFAOYSA-N
CAS
185954-27-2
Physicochemical Property
logP
4.1037
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
48.53
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
6
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 9896267
SID: 14875644
ChEMBL ID
CHEMBL217899
DrugBank ID
DB11681
Clinical Information about the Compound
Drug 1 ( TOFIMILAST )
Drug Name TOFIMILAST
Indication
Chronic obstructive pulmonary disease
Phase 2
Target(s)
Phosphodiesterase 4A (PDE4A)
Inhibitor
Phosphodiesterase 4B (PDE4B)
Inhibitor
Phosphodiesterase 4D (PDE4D)
Inhibitor